World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
49201
World Ranking
5727
National Ranking
3079

Charles G. Eberhart publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles G. Eberhart sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 646 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles G. Eberhart D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles G. Eberhart sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 109 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Charles G. Eberhart is affiliated with Johns Hopkins University School of Medicine in the United States. Their research spans multiple areas within medicine, biochemistry, genetics, and molecular biology, with a notable focus on oncology and ocular studies.

Their publication record includes contributions to major journals across several fields. Frequent publication venues include Neuro-Oncology, where they have published 55 papers, Cancer Research with 28 publications, Modern Pathology with 17, Laboratory Investigation with 14, and bioRxiv (Cold Spring Harbor Laboratory) with 8 papers.

Main fields of study for Eberhart encompass Medicine with 340 publications and Biochemistry, Genetics and Molecular Biology with 222. More specifically, their subfields extend into Molecular Biology, Genetics, Cancer Research, Ophthalmology, and Radiology, Nuclear Medicine and Imaging.

The scientist's primary research topics cover a range of cancer-related and ocular themes such as:

  • Glioma Diagnosis and Treatment
  • Chromatin Remodeling and Cancer
  • Cancer Mechanisms and Therapy
  • Epigenetics and DNA Methylation
  • Ocular Oncology and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Cancer-related molecular mechanisms research

Frequent coauthors include Eric H. Raabe, Sonika Dahiya, Jeffrey Rubens, Ilan Weinreb, and Anthony J. Gill, with varying collaboration counts ranging from 31 to 76 joint works.

Recent scientific papers featuring Eberhart or their close collaborators illustrate involvement in both clinical and molecular research agendas. Notable recent publications include:

  • "cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading" (2020, Brain Pathology)
  • "ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection" (2020, The Ocular Surface)
  • "Failure of human rhombic lip differentiation underlies medulloblastoma formation" (2022, Nature)
  • "Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth" (2020, Cell)
  • "Gelling hypotonic polymer solution for extended topical drug delivery to the eye" (2020, Nature Biomedical Engineering)

Best Publications

  • Molecular Subgroups of Medulloblastoma: The Current Consensus

    Michael D. Taylor;Paul A. Northcott;Andrey Korshunov;Marc Remke;Marc Remke

  • Medulloblastoma Comprises Four Distinct Molecular Variants

    Paul A. Northcott;Andrey Korshunov;Hendrik Witt;Thomas Hielscher

  • Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Florence M.G. Cavalli;Marc Remke;Marc Remke;Marc Remke;Ladislav Rampasek;John Peacock

  • Altered Telomeres in Tumors with ATRX and DAXX Mutations

    Christopher M. Heaphy;Roeland F. de Wilde;Yuchen Jiao;Alison P. Klein

  • Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade

    David M. Berman;Sunil S. Karhadkar;Andrew R. Hallahan;Joel I. Pritchard

  • Subgroup-specific structural variation across 1,000 medulloblastoma genomes

    Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia

  • Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.

    Xing Fan;William Matsui;Leila Khaki;Duncan Stearns

  • NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts

    Xing Fan;Leila Khaki;Thant S. Zhu;Mary E. Soules

  • Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

    David T W Jones;Barbara Hutter;Natalie Jäger;Andrey Korshunov;Andrey Korshunov

  • Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

    Yoon Jae Cho;Aviad Tsherniak;Pablo Tamayo;Sandro Santagata

  • Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.

    Benjamin W. Purow;Raqeeb M. Haque;Martha W. Noel;Qin Su

  • Cyclopamine-mediated Hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma

    Eli E. Bar;Aneeka Chaudhry;Alex Lin;Xing Fan

  • International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

    David N. Louis;Arie Perry;Peter Burger;David W. Ellison

  • A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue

    Elizabeth A. Nance;Graeme F. Woodworth;Kurt A. Sailor;Ting Yu Shih

  • Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.

    Christopher M. Heaphy;Andrea P. Subhawong;Seung Mo Hong;Michael G. Goggins

  • Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease

    Chang Hyuk Kwon;Xiaoyan Zhu;Junyuan Zhang;Lori L. Knoop

  • The neurobiology of autism

    Carlos A. Pardo;Charles G. Eberhart

  • Notch1 and notch2 have opposite effects on embryonal brain tumor growth.

    Xing Fan;Irina Mikolaenko;Ihab Elhassan;Xing Zhi Ni

  • Meiotic cell cycle requirement for a fly homologue of human deleted in Azoospermia

    Charles G. Eberhart;Jean Z. Maines;Steven A. Wasserman

  • Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

    Paul A. Northcott;Yukiko Nakahara;Xiaochong Wu;Lars Feuk

Frequent Co-Authors

Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Michael D. Taylor
Michael D. Taylor University of Toronto
Cynthia Hawkins
Cynthia Hawkins University of Toronto
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Eric Bouffet
Eric Bouffet University of Toronto
Peter C. Burger
Peter C. Burger Johns Hopkins University
Scott L. Pomeroy
Scott L. Pomeroy Boston Children's Hospital
Paul A. Northcott
Paul A. Northcott St. Jude Children's Research Hospital
James T. Rutka
James T. Rutka University of Toronto
Marc Remke
Marc Remke German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The pathway to a medical career in the USA is not limited to traditional MD programs. A wide range of related online degrees now offer greater flexibility and access to high-demand healthcare fields. Whether you're looking to advance your current role or pivot into a new area, there are options to suit various backgrounds and interests.

For nurses seeking to elevate their qualifications, a 1 year dnp program online can fast-track your leadership potential. Aspiring pharmacists can also benefit from flexible learning with pharmd online programs designed for working professionals.

If you are interested in the business or administrative side of healthcare, a specialized online health information management degree can open doors in data management, compliance, and healthcare technology. Additionally, gaining a medical coding certification online is a practical way to enter the medical billing field, which remains essential for healthcare operations.

These online programs provide alternative career pathways and allow you to advance your education while balancing work and personal commitments.

Best Scientists Citing Charles G. Eberhart

Trending Scientists